AEON Biopharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AEON Biopharma and other ETFs, options, and stocks.

About AEON

AEON Biopharma, Inc. is a biopharmaceutical company, which engages in the business of developing proprietary botulinum toxin complex, ABP-450 injection, for debilitating medical conditions. The company was founded by Robert E. 

CEO
Robert E. Bancroft
CEORobert E. Bancroft
Employees
5
Employees5
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
2012
Founded2012
Employees
5
Employees5

AEON Key Statistics

Market cap
12.47M
Market cap12.47M
Price-Earnings ratio
0.20
Price-Earnings ratio0.20
Dividend yield
Dividend yield
Average volume
214.76K
Average volume214.76K
High today
$1.08
High today$1.08
Low today
$1.02
Low today$1.02
Open price
$1.08
Open price$1.08
Volume
140.71K
Volume140.71K
52 Week high
$45.29
52 Week high$45.29
52 Week low
$0.375
52 Week low$0.375

Stock Snapshot

AEON Biopharma(AEON) stock is priced at $1.02, giving the company a market capitalization of 12.47M. It carries a P/E multiple of 0.20.

As of 2025-12-29, AEON Biopharma(AEON) stock has fluctuated between $1.02 and $1.08. The current price stands at $1.02, placing the stock +0.0% above today's low and -5.5% off the high.

AEON Biopharma(AEON) shares are trading with a volume of 140.71K, against a daily average of 214.76K.

In the last year, AEON Biopharma(AEON) shares hit a 52-week high of $45.29 and a 52-week low of $0.38.

In the last year, AEON Biopharma(AEON) shares hit a 52-week high of $45.29 and a 52-week low of $0.38.

People also own

Based on the portfolios of people who own AEON. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.